Long-term versus short-term antihypertensive medication use and medication type did not significantly affect activities of daily living performance or exercise capacity (p>0.05).
Cross-Sectional (n=27)
Does the duration and type of antihypertensive medication use affect activities of daily living, exercise capacity, and self-management levels in patients with systemic hypertension?
Functional capacity and self-management levels in hypertensive patients are not significantly affected by the duration or type of antihypertensive medication used.
p-value: p=>0.05
Abstract Introduction Although there are studies examining the effects of different antihypertensive medications on blood pressure and arterial stiffness, there is no study comparing the activities of daily living (ADLs) performance and exercise capacity of patients with systemic hypertension (HTN) according to the type and duration of medication groups. Objective The aim of the study was to compare ADLs performance, exercise capacity and self-management levels based on duration and type of antihypertensive medication use in patients with systemic HTN. Methods The demographic and clinical data of the patients were recorded. ADLs performance was evaluated by Glittre-ADL test as an objective field test. Exercise capacity was determined using 6 minute walk test (6MWT) distance. Self-management level of participants were evaluated by the Turkish version of Self-care of Hypertension Inventory Version 3.0 (SC-HI V3.0). The participants were divided into two groups based on duration medication use as ≥12 months (long-term use) and 12 months (short-term use). Results Twenty-seven patients with HTN (12 M, 15 F) and receiving antihipertansive medication therapy for at least 6 months were included in this cross-sectional study. The median age of participants were 48 (34-60) years. The median disease duration was 48 (6-192) months and median duration of medication use was 12 (6-192) months. Whereas twelve hypertensive patients were using renin-angiotensin system (RAS) blockers alone, 8 patients using combined RAS blockers and calcium channel blockers (CCBs)/diuretics, and 7 patients using other medication groups CCBs/beta blockers (BBs). The Glittre-ADL test duration, 6MWT distance and SC-HI V3.0 maintenance, monitoring and management subscores were comparable between long-term (n=17) and short-term medication use (n=10) groups and based on medication types (p0.05). The Glittre-ADL test duration was significantly correlated with 6MWT distance (r=-0.515, p=0.006) in patients with HTN. Conclusion Functional capacity indicators and self-management levels are not affected from exposure level of antihypertensive medication use and type of medication in patients with systemic HTN. In addition, higher ADLs performance is associated with better exercise capacity in HTN. These findings express the importance of assessing functional capacity and self-management level in the initial stages of the disease during cardiac rehabilitation programmes.
Calik et al. (Mon,) conducted a cross-sectional in Systemic hypertension (HTN) (n=27). Long-term (≥12 months) antihypertensive medication use vs. Short-term (<12 months) antihypertensive medication use was evaluated on Glittre-ADL test duration, 6MWT distance and SC-HI V3.0 subscores (p=>0.05). Long-term versus short-term antihypertensive medication use and medication type did not significantly affect activities of daily living performance or exercise capacity (p>0.05).